News|Articles|December 12, 2025
Lipid-Based Formulation in Customized Enteric Capsule for Oral GLP-1 Receptor Agonist Peptide Delivery
Author(s)Lonza Capsugel
Multiple factors affect oral delivery of therapeutic peptides such as acidic and enzymatic degradation in the upper gastrointestinal tract and poor intestinal Permeability.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
The Impact of Patient-Centric Formulations on Service Providers
2
PharmTech Weekly News Roundup – Week of January 12, 2026
3
Analytical Strategies for Aseptic Processing
4
Sharp Expands European Injectable Packaging Capacity With €20 million Investment
5